| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |